Cumberland Pharmaceuticals, Inc.

TN · United States · Reporting entity ID 100000005673

Total reported 2019–2025

$6.33M

#631 of 2,960 reporting companies — 0% of all reported industry payments

$2.48M in general payments across 29,774 records, plus $3.80M in research funding across 491 records.

How it breaks down

General payments $2,478,318

Research funding $3,802,888

Ownership & investment $45,540

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.